De Novo
DEN250005: Sana Device
FDA De Novo · sana health · decided Jan 16, 2026
Key facts
| De Novo number | DEN250005 |
|---|---|
| Device name | Sana Device |
| Applicant | sana health |
| Product code | QYN |
| Date received | Mar 3, 2025 |
| Decision date | Jan 16, 2026 |
| Decision | granted (DENG) |
| FDA classification | Class I |
| Review panel | Neurology |
| FEI number | 3023815184 |
At a glance
- None Later 510(k)s citing this De Novo
- None UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
- No Decision summary on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About De Novo classification requests
The De Novo pathway classifies novel low- to moderate-risk devices that have no legally marketed predicate; each granted request creates a new classification regulation and product code.
Source: U.S. Food and Drug Administration (FDA), De Novo database · Source date: